AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Nov 12 2021
News
Regulator Reviewing Reports of ‘Rare’ and Serious Condition Linked to Moderna Vaccine
Europe’s drug regulator on Thursday confirmed it is investigating reports of a blood condition in recipients of Moderna’s mRNA COVID-19 vaccine.
According to a bulletin posted by the European Medicines Agency (EMA), it is reviewing six cases of capillary leak syndrome, considered a “very rare disorder,” after they were reported in the EMA’s EudraVigilance database.
“At this stage
The Epoch TimesOct 20 2021
News
FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters
U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially.
The Food and Drug Administration’s decisions mark a big step toward expanding the U.S. booster campaign, which began with extra doses of the
Associated PressJun 08 2022
News
Moderna says new booster for fall could be 'turning point' in COVID fight
With vaccine immunity waning, and concerns over a fall surge growing, officials from Moderna announced on Wednesday that data from its study on Omicron-containing bivalent booster, revealed that it offers superior antibody response against omicron – one month after injection - compared to the company's current vaccine.
Moderna Chief Medical Officer Dr. Paul Burton told ABC News that he
ABC News (Online)Apr 28 2022
News
Moderna asks FDA to authorize COVID vaccine for emergency use in children under 6
Moderna asked Food and Drug Administration (FDA) regulators on Thursday to authorize its COVID-19 vaccine for emergency use in children under 6 years of age.
The biotech company said the shot was about 51% effective against the virus for kids under 2 years old and about 37% effective in kids ages 2 to 5.
It added that similar requests are underway with international regulatory
Fox BusinessMay 25 2021
News
Moderna's Covid-19 vaccine appears safe and powerfully effective in teens
Moderna said Tuesday that its Covid-19 vaccine provided strong protection in teens ages 12 to 17 in a late-stage trial.
The finding could pave the way for the shot to become the second authorized in the U.S. for use in teens, after the Food and Drug Administration expanded authorization of Pfizer's shot to include kids ages 12 to 15.
The company said in a press release that the
PoliticoMay 06 2021
News
Moderna says its COVID-19 vaccine is 96% effective in teens
Moderna's COVID-19 vaccine is 96% effective in teenagers 12- to 17-years-old, the drugmaker said Thursday. The company announced results of the Phase 2 trial in reporting first-quarter earnings. Its vaccine generated $1.7 billion in revenue in its fiscal first quarter.
Evidence that Moderna's vaccine is effective in teens comes as rival Pfizer is expected to receive federal
CBS News (Online)May 06 2021
News
Moderna says its COVID-19 vaccine is 96% effective in teens
Moderna's COVID-19 vaccine is 96% effective in teenagers 12- to 17-years-old, the drugmaker said Thursday. The company announced results of the Phase 2 trial in reporting first-quarter earnings. Its vaccine generated $1.7 billion in revenue in its fiscal first quarter.
Evidence that Moderna's vaccine is effective in teens comes as rival Pfizer is expected to receive federal
CBS News (Online)May 06 2021
News
Moderna says COVID-19 vaccine 96 percent effective in teens
Moderna on Thursday released the results of its COVID-19 vaccine trials for those aged 12 to 17, reporting it 96 percent effective against the virus.
The vaccine manufacturer said its trial, involving 3,235 participants, recorded 12 COVID-19 cases that emerged beginning 14 days after the first dose. The company said it had not identified any serious safety concerns to date.
The
The HillMar 23 2024
News
The Boston area built a ton of lab space. Now many of those buildings are opening empty.
Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs. The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier. But many biotech companies,
Boston.comDec 18 2020
News
U.S. FDA authorizes Moderna's COVID-19 vaccine for emergency use
Moderna Inc’s coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death toll of over 307,000 lives lost.
The FDA announced the authorization the day after the agency’s panel of outside experts endorsed its use. Moderna said it intended to apply for
Reuters